Found 391 matching trials
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms NA This study is a prospective two-arm, single blind randomized controlled tri...
Show More Location
Intrepid Spirit Center - Eglin Air Force Base
Learn More & Join Trial
Improving Autonomic Function and Balance in Diabetic Neuropathy NA Type 2 diabetes (DM2) affects nearly 20 million people in the United States...
Show More Location
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Learn More & Join Trial
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to compare how 2 different drug...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF) PHASE2 This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Show More Learn More & Join Trial
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) PHASE2 Researchers are looking for other ways to treat pulmonary arterial hyperten...
Show More Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 1930)
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
New Approaches to Smoking Cessation in Heavy Drinkers PHASE1 The purpose of this study is to develop and test an integrated cognitive-be...
Show More Location
Yale University School of Medicine
Learn More & Join Trial
Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners PHASE1 The goal of this clinical trial is to determine whether adding Integrated D...
Show More Location
The Pennsylvania State University
Learn More & Join Trial
Efficacy and Safety of Depemokimab Monotherapy Without Concomitant Use of Intranasal Corticosteroids (INCS) in Japanese Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) PHASE4 This study will evaluate the efficacy and safety of depemokimab (GSK3511294...
Show More Location
Multiple Locations
Learn More & Join Trial
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer PHASE2 This randomized phase II trial studies how well glycosylated recombinant hu...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial